NCA-029

N/A

Report date: 2024/02/29 17:48:45
NME

Base Information

Drug NameNCA-029
Drug Alias NameNCA029NCA-029
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCaseinolytic protease P activators
TargetsCaseinolytic protease P
Therapy Area/IndicationsColonic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesWest China Hospital Of Sichuan University
China Registration ClassN/A

Develop Information

Active CompaniesWest China Hospital Of Sichuan University
Inactive CompaniesN/A
Active IndicationsColonic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A